Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison.

Medic G, Lindner L, van der Weijden M, Karabis A.

Adv Ther. 2016 Mar;33(3):379-99. doi: 10.1007/s12325-016-0299-4. Review.

2.

Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.

Chauhan BF, Chartrand C, Ni Chroinin M, Milan SJ, Ducharme FM.

Cochrane Database Syst Rev. 2015 Nov 24;(11):CD007949. doi: 10.1002/14651858.CD007949.pub2. Review.

PMID:
26594816
3.

Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Scott DA, Woods B, Thompson JC, Clark JF, Hawkins N, Chambers M, Celli BR, Calverley P.

BMC Pulm Med. 2015 Nov 11;15:145. doi: 10.1186/s12890-015-0138-4.

4.

Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

Farne HA, Cates CJ.

Cochrane Database Syst Rev. 2015 Oct 22;(10):CD008989. doi: 10.1002/14651858.CD008989.pub3. Review.

PMID:
26490945
5.

Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis.

Huisman EL, Cockle SM, Ismaila AS, Karabis A, Punekar YS.

Int J Chron Obstruct Pulmon Dis. 2015 Sep 9;10:1863-81. doi: 10.2147/COPD.S87082. Review.

6.

Allergic bronchopulmonary aspergillosis in an adult with Kartagener syndrome.

Sehgal IS, Dhooria S, Bal A, Agarwal R.

BMJ Case Rep. 2015 Aug 6;2015. pii: bcr2015211493. doi: 10.1136/bcr-2015-211493. Review.

PMID:
26250371
7.

Fluticasone-formoterol: a systematic review of its potential role in the treatment of asthma.

Prosser TR, Bollmeier SG.

Ther Clin Risk Manag. 2015 Jun 2;11:889-99. doi: 10.2147/TCRM.S55116. Review.

8.

[Therapy with new LAMA / LABA combination].

Ayazpoor U.

Pneumologie. 2015 Apr;69(4):244. German. No abstract available.

PMID:
26038779
9.

[LAMA / LABA fixed combination 2 times daily].

Koczorek M.

Pneumologie. 2015 Apr;69(4):242. German. No abstract available.

PMID:
26038774
10.

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD - mixed treatment comparisons of clinical efficacy.

Stynes G, Svedsater H, Wex J, Lettis S, Leather D, Castelnuovo E, Detry M, Berry S.

Respir Res. 2015 Feb 15;16:25. doi: 10.1186/s12931-015-0184-8. Review.

11.

Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary disease.

Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ.

Cochrane Database Syst Rev. 2015 Jan 10;1:CD010139. doi: 10.1002/14651858.CD010139.pub2. Review.

PMID:
25575340
12.

Fluticasone propionate/formoterol: a fixed-combination therapy with flexible dosage.

Papi A, Blasi F, Canonica GW, Cazzola M, Centanni S, Foschino Barbaro MP, Melani AS, Paggiaro P, Ricciardolo F, Rossi A, Scichilone N.

Eur J Intern Med. 2014 Oct;25(8):695-700. doi: 10.1016/j.ejim.2014.06.022. Review.

PMID:
25051902
13.

Appraisal of lens opacity with mometasone furoate/formoterol fumarate combination in patients with COPD or asthma.

Maspero J, Cherrez I, Doherty DE, Tashkin DP, Kuna P, Kuo WL, Gates D, Nolte H, Chylack LT Jr.

Respir Med. 2014 Sep;108(9):1355-62. doi: 10.1016/j.rmed.2014.04.015.

14.

Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasis.

Goyal V, Chang AB.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD010327. doi: 10.1002/14651858.CD010327.pub2. Review.

PMID:
24913725
15.

Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.

Cates CJ, Wieland LS, Oleszczuk M, Kew KM.

Cochrane Database Syst Rev. 2014 Feb 6;(2):CD010314. doi: 10.1002/14651858.CD010314.pub2. Review.

PMID:
24504983
16.

Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.

Kew KM, Karner C, Mindus SM, Ferrara G.

Cochrane Database Syst Rev. 2013 Dec 16;(12):CD009019. doi: 10.1002/14651858.CD009019.pub2. Review.

PMID:
24343671
17.

Comparative efficacy of long-acting bronchodilators for COPD: a network meta-analysis.

Cope S, Donohue JF, Jansen JP, Kraemer M, Capkun-Niggli G, Baldwin M, Buckley F, Ellis A, Jones P.

Respir Res. 2013 Oct 7;14:100. doi: 10.1186/1465-9921-14-100.

18.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
19.

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.

Cates CJ, Jaeschke R, Schmidt S, Ferrer M.

Cochrane Database Syst Rev. 2013 Jun 7;(6):CD006924. doi: 10.1002/14651858.CD006924.pub3. Review.

PMID:
23744625
20.

Safety of formoterol in asthma clinical trials: an update.

Sears MR, Radner F.

Eur Respir J. 2014 Jan;43(1):103-14. doi: 10.1183/09031936.00004713.

Supplemental Content

Loading ...
Support Center